Catalyst Pharmaceuticals (CPRX) Change in Inventory (2019 - 2026)
Catalyst Pharmaceuticals' (CPRX) quarterly Change in Inventory came in at -$2.2 million in Q1 2026, down 1043.46% YoY from $237000.0 in Q1 2025, and down 124.25% on a QoQ basis from $9.2 million in Q4 2025.
Catalyst Pharmaceuticals (CPRX) Change in Inventory (2019 - 2026) Analysis & Trends
Catalyst Pharmaceuticals (CPRX) has 8 years of Change in Inventory data on file, last reported at -$2.2 million in Q1 2026.
- Quarterly Change in Inventory fell 1043.46% year-over-year to -$2.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $15.6 million (up 9023.43% YoY) and the FY2025 annual result came in at $18.1 million, up 364.18% from the prior year.
- Change in Inventory slipped to -$2.2 million in Q1 2026, from $9.2 million in the prior quarter.
- In the past five years, Change in Inventory ranged from a high of $9.2 million in Q4 2025 to a low of -$2.2 million in Q1 2026.
- A 5-year average of $1.4 million and a median of -$43000.0 in 2022 frame the typical range for Change in Inventory.
- The widest YoY moves for Change in Inventory: up 2121.1% in 2023, down 1241.86% in 2023.
- Tracing CPRX's Change in Inventory over 5 years: stood at -$327000.0 in 2022, then surged by 2121.1% to $6.6 million in 2023, then sank by 107.2% to -$476000.0 in 2024, then soared by 2036.97% to $9.2 million in 2025, then plunged by 124.25% to -$2.2 million in 2026.
- The last three Change in Inventory figures came in at -$2.2 million (Q1 2026), $9.2 million (Q4 2025), and $9.1 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 27.70 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 28.20 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 47.15 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -2,188.52 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -280,000.00 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 12.97 Mn |
| 10 | Catalyst Pharmaceuticals | 3.85 Bn | 3.09 Bn | 134.92 Mn | -2.24 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.24 Mn |
| Mar 31, 2026 | -2.24 Mn |
| Dec 31, 2025 | 9.22 Mn |
| Dec 31, 2025 | 9.22 Mn |
| Sep 30, 2025 | 9.09 Mn |
| Sep 30, 2025 | 9.09 Mn |
| Jun 30, 2025 | -455,000.00 |
| Jun 30, 2025 | -455,000.00 |
| Mar 31, 2025 | 237,000.00 |
| Mar 31, 2025 | 237,000.00 |
| Dec 31, 2024 | -476,000.00 |
| Dec 31, 2024 | -476,000.00 |
| Sep 30, 2024 | 2.00 Mn |
| Sep 30, 2024 | 2.00 Mn |
| Jun 30, 2024 | -1.94 Mn |
| Jun 30, 2024 | -1.94 Mn |
| Mar 31, 2024 | 4.31 Mn |
| Mar 31, 2024 | 4.31 Mn |
| Dec 31, 2023 | 6.61 Mn |
| Dec 31, 2023 | 6.61 Mn |